Ifp Advisors, Inc Csl LTD Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Aug 08, 2022	BUY	$85.56 - $107.12 $684 - $856	8 Added 0.52%	1,554 $155,000
Q4 2021 Jan 12, 2022	SELL	$97.41 - $116.74 $9,156 - $10,973	-94 Reduced 5.73%	1,546 $164,000
Q3 2021 Oct 06, 2021	BUY	$101.72 - $114.56 $6,916 - $7,790	68 Added 4.33%	1,640 $173,000
Q2 2021 Jul 13, 2021	SELL	$100.62 - $116.66 $16,803 - $19,482	-167 Reduced 9.6%	1,572 $167,000
Q1 2021 Apr 30, 2021	SELL	$95.11 - $111.11 $2,377 - $2,777	-25 Reduced 1.42%	1,739 $174,000
Q4 2020 Jan 25, 2021	BUY	$101.34 - $117.74 $3,850 - $4,474	38 Added 2.2%	1,764 $192,000
Q3 2020 Oct 29, 2020	SELL	$95.79 - $111.95 $957 - $1,119	-10 Reduced 0.58%	1,726 $176,000
Q2 2020 Aug 05, 2020	SELL	$90.75 - $104.91 $7,441 - $8,602	-82 Reduced 4.51%	1,736 $173,000
Q1 2020 May 12, 2020	SELL	$79.09 - $114.05 $28,472 - $41,058	-360 Reduced 16.53%	1,818 $165,000
Q4 2019 Jan 17, 2020	SELL	$77.9 - $98.54 $6,855 - $8,671	-88 Reduced 3.88%	2,178 $215,000
Q3 2019 Nov 07, 2019	BUY	$74.21 - $82.92 $168,159 - $187,896	2,266 New	2,266 $179,000

152K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $84B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.